The ADMIT series — Issues in Inhalation Therapy. 4) How to choose inhaler devices for the treatment of COPD

Vincken, Walter; Dekhuijzen, PN Richard; Barnes, Peter J.

doi:10.4104/pcrj.2009.00062

Cited by 85 publications

(81 citation statements)

References 89 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Therefore, patients often learn how to correctly use their ID when they are hospitalized due to an exacerbation event [20]. The experts considered that pulmonologists, followed by paramedics and GPs, were the most appropriate healthcare providers to teach and monitor patients' inhalation technique, which is in line with previous observations [2,21]. In the Delphi survey conducted previously in Spain, experts also stated that healthcare professionals should have detailed knowledge on IDs and inhalation techniques, although physicians were often unaware of their correct usage in practice [19].…”

Section: Discussionsupporting

confidence: 53%

Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus statement

Ninane

Brusselle

Louis

et al. 2013

Expert Opinion on Drug Delivery

Self Cite

View full text Add to dashboard Cite

Objectives:The study aimed to assess usage of inhalation devices in asthma and chronic obstructive pulmonary disease (COPD). Methods:In this two-round Delphi survey, 50 experts in asthma and COPD completed a 13-item, Internet-based, self-administered questionnaire about choice of inhalation device, training and monitoring of inhalation techniques, the interchangeability and the role of costs in the selection of inhalation devices. For each item, the median (central tendency) and interquartile ranges (degree of consensus) were calculated.Results: Experts considered that the choice of inhalation device was as important as that of active substance (very good consensus) and should be driven by ease of use (good to very good consensus) and teaching (very good consensus). Experts recommended giving oral and visual instructions (good consensus) and systematic monitoring inhalation techniques. Pulmonologists and paramedics have predominantly educational roles (very good consensus). Experts discouraged inhalation device interchangeability (good consensus) and switching for cost reasons (good to very good consensus) without medical consultation (good consensus). Conclusions:The results of this survey thus suggested that inhalation devices are as important as active substances and training and monitoring are essential in ensuring effective treatment of asthma and COPD. Inhalation device switching without medical consultation should be avoided.

show abstract

Section: Discussionsupporting

confidence: 53%

Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus statement

Ninane

Brusselle

Louis

et al. 2013

Expert Opinion on Drug Delivery

Self Cite

View full text Add to dashboard Cite

show abstract

“…nebuliser or inhaler) and various behavioural approaches (e.g. assessing inhaler technique); however, the effectiveness of such interventions has not been confirmed due to insufficient study [147][148][149].…”

Section: Standard Pharmacological Therapiesmentioning

confidence: 99%

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD

et al. 2015

View full text Add to dashboard Cite

Chronic obstructive pulmonary disease (COPD) is a leading cause of morbidity, mortality, and resource use worldwide. The goal of this official American Thoracic Society (ATS)/European Respiratory Society (ERS) research statement is to describe evidence related to diagnosis, assessment and management; identify gaps in knowledge; and make recommendations for future research. It is not intended to provide clinical practice recommendations on COPD diagnosis and management.Clinicians, researchers, and patient advocates with expertise in COPD were invited to participate. A literature search of Medline was performed, and studies deemed relevant were selected. The search was not a systematic review of the evidence. Existing evidence was appraised and summarised, and then salient knowledge gaps were identified.Recommendations for research that addresses important gaps in the evidence in all areas of COPD were formulated via discussion and consensus.Great strides have been made in the diagnosis, assessment and management of COPD, as well as understanding its pathogenesis. Despite this, many important questions remain unanswered. This ATS/ ERS research statement highlights the types of research that leading clinicians, researchers, and patient advocates believe will have the greatest impact on patient-centred outcomes. @ERSpublications ATS/ERS statement: which types of research will have the greatest future impact on patientcentred outcomes in COPD? http://ow.ly/I54Hb

show abstract

“…DPIs such as the Turbohaler and the Diskus DPI, which require breath actuation, involving inspiratory effort and a need for a certain flow rate [2,4,17,18].…”

Section: Discussionmentioning

confidence: 99%

A Handling Study to Assess the Use of the Respimat® Soft Mist™ Inhaler in Children Aged 4–12 Years

et al. 2015

View full text Add to dashboard Cite

The ADMIT series — Issues in Inhalation Therapy. 4) How to choose inhaler devices for the treatment of COPD

Cited by 85 publications

References 89 publications

Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus statement

Usage of inhalation devices in asthma and chronic obstructive pulmonary disease: a Delphi consensus statement

An official American Thoracic Society/European Respiratory Society statement: research questions in COPD

A Handling Study to Assess the Use of the Respimat® Soft Mist™ Inhaler in Children Aged 4–12 Years

Contact Info

Product

Resources

About